Radiolabelled Molecules for Brain Imaging with PET and SPECT

Radiolabelled Molecules for Brain Imaging with PET and SPECT


English[eng]


SV2A||SV2B||SV2C||microPET||[18F]UCB-H||epilepsy||PBIF||distribution volume||blocking assay||preclinical imaging||Alzheimer’s disease (AD)||network measure||graph theory||brain network||positron emission tomography (PET)||persistent homology||Phosphodiesterase 2A (PDE2A)||Positron Emission Tomography (PET)||Benzoimidazotriazine (BIT)||fluorinated||Mouse Liver Microsomes (MLM)||cyclic nucleotide phosphodiesterase||PDE2A radioligand||nitro-precursor||fluorine-18||in vitro autoradiography||PET imaging||opioid receptors||positron emission tomography||radiotracers||μOR-, δOR-, κOR- and ORL1-ligands||movement disorders||pain||drug dependence||GBM||biomarkers||Sigma 1||Sigma 2||PD-L1||PARP||IDH||Alzheimer’s disease||Parkinson’s disease||β-amyloid plaques||neurofibrillary tangles||α-synucleinopathy||diagnostic imaging probes||orexin receptors||PET||radiotracer||imaging||alpha 7||nicotinic acetylcholine receptors||nAChR||autoradiography||amino acid||FET||FACBC||FDOPA||immunoPET||molecular imaging||glioma||brain metastases||adenosine A2A receptor||rotenone-based mouse model||[18F]FESCH||two-step one-pot radiosynthesis